4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001808968-25-000003
CHIEF EXECUTIVE OFFICER sold 3,428 shares at $79.07 ($271,052)
- CHIEF EXECUTIVE OFFICER acquired 15,625 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Klein Matthew B. · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-01 | Grant or award : show line 1 in the form 10b5-1 | +15,625 | 353,392 | D | ||
| 2025-12-02 | Sale : show line 2 in the form 10b5-1 | −3,428 | $79.07 | $271,052 | 349,964 | D |
| Open-market sales · 3,428 sh · avg $79.07 · $271,052 | ||||||
Loading xslF345X05/form4-12032025_051202.xml…